tiprankstipranks
Trending News
More News >
Tenet Healthcare (THC)
NYSE:THC
US Market

Tenet Healthcare (THC) Ratios

Compare
963 Followers

Tenet Healthcare Ratios

THC's free cash flow for Q4 2025 was $0.42. For the 2025 fiscal year, THC's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.76 1.76 1.78 1.51 1.34
Quick Ratio
1.68 1.68 1.70 1.42 1.25
Cash Ratio
0.65 0.65 0.70 0.26 0.19
Solvency Ratio
0.11 0.11 0.20 0.06 0.06
Operating Cash Flow Ratio
0.79 0.79 0.47 0.50 0.24
Short-Term Operating Cash Flow Coverage
44.81 44.81 6.92 19.78 7.47
Net Current Asset Value
$ -12.86B$ -12.86B$ -12.71B$ -15.64B$ -16.57B
Leverage Ratios
Debt-to-Assets Ratio
0.44 0.44 0.50 0.53 0.56
Debt-to-Equity Ratio
3.12 3.12 3.43 9.33 13.20
Debt-to-Capital Ratio
0.76 0.76 0.77 0.90 0.93
Long-Term Debt-to-Capital Ratio
0.76 0.76 0.75 0.90 0.93
Financial Leverage Ratio
7.03 7.03 6.94 17.61 23.78
Debt Service Coverage Ratio
5.80 48.97 5.09 3.02 2.64
Interest Coverage Ratio
5.69 0.00 7.21 2.79 2.62
Debt to Market Cap
0.63 0.73 1.06 1.95 2.89
Interest Debt Per Share
156.82 145.00 156.37 156.47 149.34
Net Debt to EBITDA
2.30 2.39 1.64 4.07 4.62
Profitability Margins
Gross Profit Margin
55.91%41.41%39.72%37.98%36.76%
EBIT Margin
16.91%16.14%29.39%12.25%11.66%
EBITDA Margin
20.96%20.19%33.35%16.49%16.04%
Operating Profit Margin
16.46%16.46%28.82%12.22%12.17%
Pretax Profit Margin
13.14%13.14%25.40%7.87%7.01%
Net Profit Margin
6.60%6.60%15.49%2.97%2.14%
Continuous Operations Profit Margin
11.11%11.11%19.67%6.38%5.22%
Net Income Per EBT
50.25%50.25%60.98%37.79%30.56%
EBT Per EBIT
79.82%79.82%88.11%64.42%57.65%
Return on Assets (ROA)
4.74%4.74%11.06%2.16%1.51%
Return on Equity (ROE)
34.82%33.34%76.72%38.00%35.99%
Return on Capital Employed (ROCE)
13.91%13.91%24.19%10.66%10.29%
Return on Invested Capital (ROIC)
11.72%11.72%18.51%8.60%7.61%
Return on Tangible Assets
8.21%8.21%18.99%3.67%2.63%
Earnings Yield
6.75%7.79%26.16%7.95%7.88%
Efficiency Ratios
Receivables Turnover
8.31 8.31 6.77 6.04 5.54
Payables Turnover
6.91 9.18 9.63 9.05 8.06
Inventory Turnover
27.00 35.88 36.00 31.00 29.94
Fixed Asset Turnover
3.37 3.37 2.92 2.81 2.53
Asset Turnover
0.72 0.72 0.71 0.73 0.71
Working Capital Turnover Ratio
6.42 6.31 7.15 10.51 11.05
Cash Conversion Cycle
4.62 14.35 26.16 31.91 32.82
Days of Sales Outstanding
43.93 43.93 53.94 60.47 65.90
Days of Inventory Outstanding
13.52 10.17 10.14 11.77 12.19
Days of Payables Outstanding
52.83 39.76 37.92 40.33 45.27
Operating Cycle
57.45 54.11 64.08 72.24 78.09
Cash Flow Ratios
Operating Cash Flow Per Share
40.27 38.97 21.12 23.36 10.13
Free Cash Flow Per Share
28.78 27.85 11.52 15.97 3.00
CapEx Per Share
11.49 11.12 9.61 7.39 7.13
Free Cash Flow to Operating Cash Flow
0.71 0.71 0.55 0.68 0.30
Dividend Paid and CapEx Coverage Ratio
3.50 3.50 2.20 3.16 1.42
Capital Expenditure Coverage Ratio
3.50 3.50 2.20 3.16 1.42
Operating Cash Flow Coverage Ratio
0.27 0.27 0.14 0.16 0.07
Operating Cash Flow to Sales Ratio
0.17 0.17 0.10 0.12 0.06
Free Cash Flow Yield
12.15%14.02%9.12%21.13%6.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.81 12.83 3.82 12.57 12.69
Price-to-Sales (P/S) Ratio
0.98 0.85 0.59 0.37 0.27
Price-to-Book (P/B) Ratio
4.94 4.28 2.93 4.78 4.57
Price-to-Free Cash Flow (P/FCF) Ratio
8.23 7.13 10.96 4.73 16.25
Price-to-Operating Cash Flow Ratio
5.88 5.10 5.98 3.24 4.82
Price-to-Earnings Growth (PEG) Ratio
2.39 -0.24 <0.01 0.22 -0.23
Price-to-Fair Value
4.94 4.28 2.93 4.78 4.57
Enterprise Value Multiple
6.96 6.59 3.42 6.33 6.32
Enterprise Value
31.11B 28.34B 23.54B 21.45B 19.44B
EV to EBITDA
6.96 6.59 3.42 6.33 6.32
EV to Sales
1.46 1.33 1.14 1.04 1.01
EV to Free Cash Flow
12.30 11.20 21.09 13.22 60.55
EV to Operating Cash Flow
8.79 8.01 11.50 9.04 17.95
Tangible Book Value Per Share
-40.64 -39.34 -36.54 -60.68 -64.89
Shareholders’ Equity Per Share
48.00 46.46 43.04 15.82 10.68
Tax and Other Ratios
Effective Tax Rate
0.15 0.15 0.23 0.19 0.26
Revenue Per Share
242.39 234.61 213.25 202.17 179.32
Net Income Per Share
16.00 15.49 33.02 6.01 3.84
Tax Burden
0.50 0.50 0.61 0.38 0.31
Interest Burden
0.78 0.81 0.86 0.64 0.60
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.20 0.00 0.43 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.69 2.52 0.50 1.81 1.08
Currency in USD